title: Flt3-ligand plasmid prevents the development of pathophysiological features of chronic asthma in a mouse model.
abstract: Airway inflammation and remodeling are primary characteristics of long-standing asthma. A balance between the T(H)1/T(H)2 cytokines regulates the accumulation and activation of inflammatory cells, including mast cells and eosinophils. Recently, we demonstrated that pUMVC3-hFLex, an active plasmid, mammalian expression vector for the secretion of Flt3-L, reversed established airway hyperresponsiveness (AHR) in a murine model of acute allergic airway inflammation. The present experiments were undertaken to examine the effect of pUMVC3-hFLex in a chronic model of allergic airway inflammation that was established in Balb/c mice by sensitization and challenge with ovalbumin (OVA). pUMVC3-hFLex or the control plasmid, pUMVC3, were administered by injection into the muscle interior tibialis. Treatment with pUMVC3-hFLex completely reversed established AHR (p < 0.05), and this effect continued even after several exposures to the allergen (p < 0.05). pUMVC3-hFLex treatment prevented the development of goblet cell hyperplasia and subepithelial fibrosis, and significantly reduced serum levels of IL-4 and IL-5, and increased serum IL-10 levels (p < 0.05) with no effect on serum IL-13. Serum IgE or serum total and anti-OVA IgG1 and IgG2a levels did not change. Total BALF cellularity and BALF IL-5 levels were reduced (p < 0.05), but there was no significant effect on BALF IL-10 and IL-13. These results suggest that pUMVC3-hFLex treatment can prevent the development of airway remodeling and maintain airway protection in chronic experimental asthma model, and might provide a novel approach for treating chronic asthma.
authors: Department of Biomedical Sciences, Medical Microbiology & Immunology, Creighton University School of Medicine, Omaha, NE 68178, USA.
authors: Jehad H
authors: JH
authors: Edwan
authors: Devendra K
authors: DK
authors: Agrawal
mesh_terms: D000818:Animals; D001249:Asthma / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003094:Collagen / Q000378:metabolism; D016207:Cytokines / Q000097:blood / Q000276:immunology; D005260:Female; D020397:Goblet Cells / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007132:Immunoglobulin Isotypes / Q000276:immunology; D007167:Immunotherapy / Q000379:methods; D008565:Membrane Proteins / Q000097:blood / Q000235:genetics* / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000276:immunology / Q000494:pharmacology; D010957:Plasmids / Q000235:genetics / Q000276:immunology
chemical_list: D016207:Cytokines; D007074:Immunoglobulin G; D007132:Immunoglobulin Isotypes; D008565:Membrane Proteins; C084881:flt3 ligand protein; D007073:Immunoglobulin E; D010047:Ovalbumin; D003094:Collagen
references: Nat Immunol. 2001 Aug;2(8):725-31
references: 11477409
references: Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S46-51
references: 11734466
references: J Exp Med. 1996 Jul 1;184(1):19-29
references: 8691133
references: Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1-53
references: 9520807
references: J Clin Invest. 1993 Jan;91(1):133-40
references: 8423213
references: Blood. 1994 May 15;83(10):2795-801
references: 8180375
references: Nat Immunol. 2002 Feb;3(2):135-42
references: 11812990
references: Am Rev Respir Dis. 1993 Feb;147(2):405-10
references: 8430966
references: Chest. 1992 Apr;101(4):916-21
references: 1555462
references: J Allergy Clin Immunol. 2000 Oct;106(4):651-9
references: 11031335
references: Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):766-75
references: 9309991
references: J Immunol. 2002 Feb 1;168(3):1080-6
references: 11801641
references: J Immunol. 2004 Apr 15;172(8):5016-23
references: 15067083
references: Clin Exp Allergy. 2001 Jun;31(6):934-42
references: 11422160
references: Science. 1998 Dec 18;282(5397):2261-3
references: 9856950
references: Science. 1998 Dec 18;282(5397):2258-61
references: 9856949
references: Am J Respir Cell Mol Biol. 2004 Jul;31(1):62-8
references: 14975941
references: J Immunol. 2003 Feb 15;170(4):2083-92
references: 12574379
references: Am J Respir Cell Mol Biol. 1990 Nov;3(5):507-11
references: 2223105
references: Cytokine. 2001 Aug 7;15(3):138-47
references: 11554783
references: Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7821-5
references: 8755560
references: Clin Exp Allergy. 1994 Jan;24(1):73-80
references: 8156448
references: Am J Respir Cell Mol Biol. 2000 Aug;23(2):241-6
references: 10919992
references: Int Immunopharmacol. 2001 Nov;1(12):2081-9
references: 11710537
references: Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):115-8
references: 7613115
references: Lancet. 1989 Mar 11;1(8637):520-4
references: 2466184
references: J Cell Physiol. 1996 May;167(2):290-6
references: 8613470
references: Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 2):S58-61
references: 8756790
references: Lab Invest. 1999 Dec;79(12):1559-71
references: 10616206
references: J Pharmacol Toxicol Methods. 1998 Apr;39(3):163-8
references: 9741391
references: J Clin Invest. 2003 Oct;112(7):1029-36
references: 14523040
references: J Exp Med. 1997 Jun 16;185(12):2143-56
references: 9182686
references: Am J Respir Cell Mol Biol. 1996 May;14(5):425-38
references: 8624247
references: Am J Respir Crit Care Med. 1998 Dec;158(6):1936-44
references: 9847289
references: J Immunol. 1997 Nov 15;159(10):4772-80
references: 9366401
references: Eur Respir J. 1996 Jul;9(7):1395-401
references: 8836649
references: J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1041-53
references: 10856134
references: Nature. 1997 Oct 16;389(6652):737-42
references: 9338786
references: Cell. 1995 Dec 15;83(6):851-7
references: 8521509
references: J Clin Invest. 1999 Mar;103(6):779-88
references: 10079098